Search research articles
Contact Us
Filters
Showing results (181-190 of 414) with videos related to
Page
of 42
Sort By:
Arthritis and Rheumatism
|
February 1, 1994
Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins
S Doré, J P Pelletier, J A DiBattista, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 1, 1994
Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
J Martel-Pelletier, R McCollum, N Fujimoto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1994
Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway
J A DiBattista, J Martel-Pelletier, N Fujimoto, et al.
The Journal of Rheumatology. Supplement
|
February 1, 1995
Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts
J A DiBattista, J P Pelletier, M Zafarullah, et al.
Osteoarthritis and Cartilage
|
May 18, 1999
Carprofen reduces the structural changes and the abnormal subchondral bone metabolism of experimental osteoarthritis
J P Pelletier, D Lajeunesse, G Hilal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 24, 2001
Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts
G Hilal, F Massicotte, J Martel-Pelletier, et al.
Clinical and Experimental Rheumatology
|
June 21, 2008
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells
S Kwan Tat, J-P Pelletier, D Lajeunesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
January 18, 2005
Successful repair of tracheal dehiscence after heart-lung transplantation
Marc P Pelletier, Michael Coady, Shazad Ahmed, et al.
Arthritis and Rheumatism
|
May 1, 1985
Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis
J P Pelletier, J Martel-Pelletier, L Ghandur-Mnaymneh, et al.
The Journal of Clinical Investigation
|
August 1, 1989
Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage
D D Dean, J Martel-Pelletier, J P Pelletier, et al.
Page
of 42
Search research articles
Search
Showing results (181-190 of 414) with videos related to
Sort By:
Page
of 42
Arthritis and Rheumatism
|
February 1, 1994
Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins
S Doré, J P Pelletier, J A DiBattista, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
June 1, 1994
Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis
J Martel-Pelletier, R McCollum, N Fujimoto, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1994
Prostaglandins E2 and E1 inhibit cytokine-induced metalloprotease expression in human synovial fibroblasts. Mediation by cyclic-AMP signalling pathway
J A DiBattista, J Martel-Pelletier, N Fujimoto, et al.
The Journal of Rheumatology. Supplement
|
February 1, 1995
Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts
J A DiBattista, J P Pelletier, M Zafarullah, et al.
Osteoarthritis and Cartilage
|
May 18, 1999
Carprofen reduces the structural changes and the abnormal subchondral bone metabolism of experimental osteoarthritis
J P Pelletier, D Lajeunesse, G Hilal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 24, 2001
Endogenous prostaglandin E2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts
G Hilal, F Massicotte, J Martel-Pelletier, et al.
Clinical and Experimental Rheumatology
|
June 21, 2008
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells
S Kwan Tat, J-P Pelletier, D Lajeunesse, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
January 18, 2005
Successful repair of tracheal dehiscence after heart-lung transplantation
Marc P Pelletier, Michael Coady, Shazad Ahmed, et al.
Arthritis and Rheumatism
|
May 1, 1985
Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis
J P Pelletier, J Martel-Pelletier, L Ghandur-Mnaymneh, et al.
The Journal of Clinical Investigation
|
August 1, 1989
Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage
D D Dean, J Martel-Pelletier, J P Pelletier, et al.
Page
of 42